ALLERGY THERAPEUTICS PLC Logo

ALLERGY THERAPEUTICS PLC

Immunology company developing aluminum-free vaccines and therapies for allergies.

AGY | IL

Overview

Corporate Details

ISIN(s):
GB00B02LCQ05
LEI:
213800PQ7AHK7KGVOE23
Country:
United Kingdom
Address:
DOMINION WAY, BN14 8SA WORTHING

Description

Allergy Therapeutics PLC is an immunology company focused on the research, development, diagnosis, and treatment of allergic disorders. The company specializes in creating therapies for allergy treatment and prevention, with a key focus on developing aluminum-free immunotherapies and allergy vaccines. These treatments aim to address the underlying cause of the allergy rather than merely managing symptoms. Leveraging its specialist expertise in immunology, the company strives to develop effective and convenient solutions to improve the quality of life for individuals with allergies.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-11-10 14:22
Director/PCA Dealing
English 18.0 KB
2023-11-10 14:11
Holding(s) in Company
English 55.6 KB
2023-11-09 11:48
Exercise of Options and Total Voting Rights
English 13.6 KB
2023-11-06 08:00
Update on funding
English 12.5 KB
2023-10-20 18:17
Holding(s) in Company
English 54.1 KB
2023-10-16 18:39
Southern Fox: Form 8.3 – Allergy Therapeutics Plc
English 50.5 KB
2023-10-16 16:03
Holding(s) in Company
English 55.5 KB
2023-10-13 08:00
Result of Open Offer and Subscription
English 47.9 KB
2023-10-02 18:53
Block Listing Interim Review
English 19.9 KB
2023-09-27 13:04
Publication of Open Offer Circular – Amendment
English 33.2 KB
2023-09-27 08:01
Publication of Open Offer Circular
English 31.7 KB
2023-09-27 08:00
Unaudited Preliminary Results 2023
English 394.6 KB
2023-09-26 08:00
Phase I VLP Peanut PROTECT trial progress
English 16.1 KB
2023-09-22 08:00
Satisfaction of FDI clearance conditions
English 17.3 KB
2023-08-10 08:00
Trading update for the year ended 30 June 2023
English 18.4 KB

Automate Your Workflow. Get a real-time feed of all ALLERGY THERAPEUTICS PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ALLERGY THERAPEUTICS PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ALLERGY THERAPEUTICS PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.